SCHEMBL4088440

SCHEMBL4088440

CCN(CC)CCOc1ccc(CC(C)=O)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.59
LTA4H P09960 1/20 0.59
CYP2D6 P10635 1/20 0.59
CYP2C9 P11712 1/20 0.59
CYP2C19 P33261 1/20 0.59
HTT P42858 1/20 0.59
EBP Q15125 1/20 0.56
SIGMAR1 Q99720 1/20 0.56
MAOB P27338 1/20 0.56
ACACB O00763 1/20 0.55
HRH3 Q9Y5N1 1/20 0.52
LMNA P02545 1/20 0.51
SCN1A P35498 1/20 0.51
SCN2A Q99250 1/20 0.51
SCN3A Q9NY46 1/20 0.51
KCNH2 Q12809 1/20 0.50
BCHE P06276 1/20 0.50
ACHE P22303 1/20 0.50
MAPT P10636 1/20 0.50
CHRNA7 P36544 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4212893 0.88 CYP1A2 (0.63) CYP1A2LTA4HCYP2D6CYP2C9CYP2C19
SCHEMBL13713114 0.85 CYP1A2 (0.56) CYP1A2LTA4HCYP2D6CYP2C9CYP2C19
SCHEMBL874125 0.85 CYP1A2 (0.56) CYP1A2LTA4HCYP2D6CYP2C9CYP2C19
SCHEMBL7150669 0.84 HRH3 (0.62) CYP1A2LTA4HCYP2C19HRH3
SCHEMBL9632476 0.82 LMNA (0.60) CYP1A2CYP2D6CYP2C19ACACBLMNA
SCHEMBL8347541 0.82 KDM4E (0.68) CYP1A2CYP2D6LMNA
Ethylene SCHEMBL10898156 0.81 HRH3 (0.58) CYP1A2LTA4HCYP2C19HRH3
SCHEMBL9706125 0.81 EBP (0.72) CYP1A2LTA4HCYP2D6CYP2C9CYP2C19
SCHEMBL3149568 0.81 EBP (0.69) CYP2D6HTTEBPSIGMAR1MAOB
SCHEMBL4703442 0.81 EBP (0.59) CYP1A2LTA4HCYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090181962-A1 Substituted thiophene compounds ASTRAZENECA AB, A SWEDEN CORPORATION 2009-07-16 US disclosed
US-7358376-B2 Substituted Thiophene compounds ASTRAZENECA AB (SE) 2008-04-15 US disclosed
EP-1261600-B1 HETEROAROMATIC CARBOXAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF THE ENZYME IKK-2 ASTRAZENECA AB (SE) 2004-05-06 EP disclosed
EP-1261600-A1 HETEROAROMATIC CARBOXAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF THE ENZYME IKK-2 AstraZeneca AB (SE) 2002-12-04 EP disclosed
US-20020107252-A1 Novel Compounds ASTRAZENECA AB (SE) 2002-08-08 US disclosed
WO-2001058890-A1 HETEROAROMATIC CARBOXAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF THE ENZYME IKK-2 ASTRAZENECA AB (SE) 2001-08-16 WO disclosed
EP-0070133-B1 SECONDARY PHENYLETHANOL AMINES, PROCESSES FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL APPLICATION BEECHAM GROUP PLC (GB) 1986-05-14 EP disclosed
EP-0070133-A2 Secondary phenylethanol amines, processes for their preparation and their pharmaceutical application BEECHAM GROUP PLC (GB) 1983-01-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181962-A1 Substituted thiophene compounds ABCG2, SULT1E1, TPMT CYP1A2 4/4885LTA4H 1553/4885CYP2D6 9/4885
US-20020107252-A1 Novel Compounds UGT1A1, CYP1B1, CYP1A1 CYP1A2 4/4885LTA4H 1948/4885CYP2D6 12/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.